PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.\', \'Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.\', \'Department of Infectious Disease, Imperial College London, London, United Kingdom.\', \'The Francis Crick Institute, London, United Kingdom.\', \'Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1010022
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34855916
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all